Why US Dental Labs are quietly adding Clear Aligners to their portfolio
- K Line Europe
- May 14
- 5 min read
Across the United States, a structural shift is underway in the dental laboratory industry. Dentists are asking their labs for clear aligners. Most labs cannot produce them. And the labs that find a way to fill that gap are positioning themselves for a decade of growth, while those that do not are watching long-standing dentist relationships shift to competitors.
This is not loud. There are no press releases. It is happening one consultation at a time. But the numbers behind it are clear, and the strategic implications for US labs are significant.
The clear aligner market is growing faster than nearly any segment in dentistry
The global clear aligners market reached $6.58 billion in 2025 and is projected to grow at a 9.5% CAGR through 2032, reaching approximately $12.25 billion. North America alone holds 42.7% of that global share, with the US market valued at $1.91 billion by 2026.
This sits inside an even larger trend. The global dental laboratories market reached $24.26 billion in 2025 and is projected to grow at a 6.8% CAGR to $40.76 billion by 2033, with the orthodontic segment specifically projected to grow at the highest rate of any segment in dental laboratory services.
Centralized lab production accounted for 79.55% of all clear aligner manufacturing in 2025. Aligner production is highly concentrated, not distributed.
Most labs receive cases, plan treatment, and ship aligners produced elsewhere, rather than manufacturing them in-house.
The capability gap explains the concentration
There is a reason aligner manufacturing has remained concentrated in a small number of specialized producers. Setting up in-house aligner production is operationally and financially intensive.
The required equipment alone, including 3D printers, thermoforming machines, supporting digital workflow infrastructure, and management software, runs into hundreds of thousands of dollars in capital expenditure. Building the supporting clean production environment, training technicians on aligner-specific workflows, and developing or licensing treatment planning software adds further time and cost. EON Dental estimates that setting up a full in-house aligner manufacturing operation can take a year to eighteen months from start to first production.
For most of the 4,216 US dental laboratories tracked by IBISWorld in 2025, this scale of investment is not realistic. The industry has actually contracted at a 2.8% CAGR from 2020 to 2025, even as overall demand for dental services has grown.
There is also a regulatory dimension. Clear aligners are FDA-regulated medical devices in the US. Manufacturing them under FDA Class II requirements demands documented quality management systems, ISO 13485 compliance, biocompatibility testing under ISO 10993, and ongoing regulatory oversight. For labs accustomed to producing crowns and bridges, this is unfamiliar regulatory territory.
The pressure on labs is intensifying
While the capability gap remains real, the demand pressure is intensifying. Several factors are converging.
First, dental service organizations (DSOs) are reshaping the customer base for labs. DSOs such as Heartland Dental standardized on iTero scanners in 2024 and have used their purchasing scale to negotiate up to 30% discounts on aligner pricing. This consolidation pushes smaller labs toward either niche specialization or partnership-based scale.
Second, dentists themselves are changing their treatment patterns. Adults held 74.58% of the clear aligner market share in 2025, and the orthodontic segment is the fastest-growing segment in dental laboratory services. The dentist who once referred patients for traditional orthodontics is increasingly handling aligner cases directly.
Third, geopolitical factors are shifting supply chains. US tariffs on Chinese medical devices and the broader push toward domestic manufacturing have made US-produced aligners more strategically valuable.
The strategic response: from aligner brand to manufacturing partner
A new partnership model is emerging in response. Rather than building their own production capacity, US labs are partnering with established aligner manufacturers who can produce clear aligners under the lab's own brand.
A lab choosing between aligner brands is making a product decision. A lab choosing between manufacturing partners is making a strategic, long-term operational decision.
The criteria are different. Lead times matter. So do regulatory certifications, production scale, brand flexibility, geographic proximity, and SLA reliability. The labs taking this seriously are asking pointed questions about all of them.
What to evaluate in a manufacturing partner
Five factors separate the manufacturing partners worth considering from the ones that are not.
Production scale and consistency. A manufacturing partner needs to handle peak volume without slowing turnaround. Look for partners with documented production capacity, multiple facilities, and a proven track record of meeting service-level agreements. Production scale is not just about capacity; it is about predictability under load.
Regulatory compliance. FDA clearance is the baseline for US distribution. For labs serving international clients or planning to expand, additional certifications like CE (European) and MHRA (UK) provide important coverage. ISO 13485 medical device quality management is now considered standard for aligner manufacturers serving the US market.
Brand flexibility. The whole point of this partnership model is keeping the lab's name on the case. Some manufacturers limit branding to packaging. Others allow full case-level branding, including custom case colors, logos, and patient-facing materials. The difference matters significantly for how dentists and patients perceive the work.
Geographic proximity. Locally manufactured aligners ship faster, navigate fewer supply chain risks, and feel more reliable to lab customers facing tighter delivery expectations. US-based production is increasingly valued for both operational and political reasons.
Operational fit. A partnership only works if it integrates cleanly with how the lab already operates. The right partner makes adding aligners a workflow expansion rather than a workflow rebuild. This includes digital file compatibility, scanner integration, and case management workflows that align with the lab's existing infrastructure.
The window is narrowing
The labs that close this capability gap in the next 12 to 18 months will own their dentist relationships for the next decade. The ones that do not will continue to watch aligner cases, and increasingly broader dental workflows, move toward whoever else is offering the service.
The clear aligner segment is structurally growing faster than nearly any other segment in dental laboratory services. The shift from aligner brand to manufacturing partner is happening, and the labs that recognise it first have a significant operational and competitive advantage.
Add aligners under your own brand without rebuilding your operation
K Line manufactures private label clear aligners for dental and orthodontic labs worldwide. If your dentists are asking for aligners and you need a production partner rather than a brand to resell, this is where that conversation starts.
✔ 5-day production from FDA, CE, and MHRA-certified US and European facilities.
✔ Full private label — your name on the case, the packaging, and all patient-facing materials.
✔ ISO 13485-compliant quality management, with 150+ lab partners across 40+ countries.
Talk to our team about what integrated production looks like for your brand.
Comments